Author | Victor Y. Yazbeck, MD | OncLive

Author | Victor Y. Yazbeck, MD


Dr. Yazbeck on Idelalisib Plus BR in Relapsed/Refractory CLL

January 25, 2016


Victor Y. Yazbeck, MD, assistant professor, Hematology-Oncology, Internal Medicine, Virginia Commonwealth University (VCU) School of Medicine, VCU Massey Cancer Center, discusses a phase III study examining idelalisib plus bendamustine rituximab in patients with relapsed/refractory chronic lymphocytic leukemia.